Efficacy of BRL 25000 against Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii in urinary tract infections.

Synergism between amoxicillin and clavulanic acid was not expected against cephalosporinase-producing bacterial strains because clavulanic acid has little inhibitory action on cephalosporinases. However, in a clinical trial of BRL 25000 (amoxicillin-clavulanic acid), excellent results were obtained...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Nakazawa, H, Hashimoto, T, Nishiura, T, Mitsuhashi, S
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1983
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185341/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6357078/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.24.3.437
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!